290 related articles for article (PubMed ID: 12653944)
1. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).
Lee AH; Denley HE; Pinder SE; Ellis IO; Elston CW; Vujovic P; Macmillan RD; Evans AJ;
Histopathology; 2003 Apr; 42(4):331-6. PubMed ID: 12653944
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
Dillon MF; McDermott EW; Hill AD; O'Doherty A; O'Higgins N; Quinn CM
Ann Surg Oncol; 2007 Feb; 14(2):704-11. PubMed ID: 17151788
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
Histopathology; 2008 Dec; 53(6):650-7. PubMed ID: 19076681
[TBL] [Abstract][Full Text] [Related]
4. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.
Rakha EA; Ho BC; Naik V; Sen S; Hamilton LJ; Hodi Z; Ellis IO; Lee AH
Histopathology; 2011 Mar; 58(4):626-32. PubMed ID: 21371081
[TBL] [Abstract][Full Text] [Related]
5. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
Carder PJ; Liston JC
J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
[TBL] [Abstract][Full Text] [Related]
6. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
[TBL] [Abstract][Full Text] [Related]
7. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
[TBL] [Abstract][Full Text] [Related]
8. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
Carder PJ; Garvican J; Haigh I; Liston JC
Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
[TBL] [Abstract][Full Text] [Related]
9. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.
Hayes BD; O'Doherty A; Quinn CM
J Clin Pathol; 2009 Dec; 62(12):1136-40. PubMed ID: 19946101
[TBL] [Abstract][Full Text] [Related]
10. Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology.
Noske A; Pahl S; Fallenberg E; Richter-Ehrenstein C; Buckendahl AC; Weichert W; Schneider A; Dietel M; Denkert C
Hum Pathol; 2010 Apr; 41(4):522-7. PubMed ID: 20004938
[TBL] [Abstract][Full Text] [Related]
11. The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions.
Ibrahim AE; Bateman AC; Theaker JM; Low JL; Addis B; Tidbury P; Rubin C; Briley M; Royle GT
J Clin Pathol; 2001 Feb; 54(2):121-5. PubMed ID: 11215280
[TBL] [Abstract][Full Text] [Related]
12. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3).
Houssami N; Ciatto S; Bilous M; Vezzosi V; Bianchi S
Br J Cancer; 2007 Apr; 96(8):1253-7. PubMed ID: 17438578
[TBL] [Abstract][Full Text] [Related]
13. Vacuum assisted stereotactic guided mammotome biopsies in the management of screen detected microcalcifications: experience of a large breast screening centre.
Kumaroswamy V; Liston J; Shaaban AM
J Clin Pathol; 2008 Jun; 61(6):766-9. PubMed ID: 18326021
[TBL] [Abstract][Full Text] [Related]
14. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis.
Harvey JM; Sterrett GF; Frost FA
Pathology; 2002 Oct; 34(5):410-6. PubMed ID: 12408338
[TBL] [Abstract][Full Text] [Related]
15. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
Lucioni M; Rossi C; Lomoro P; Ballati F; Fanizza M; Ferrari A; Garcia-Etienne CA; Boveri E; Meloni G; Sommaruga MG; Ferraris E; Lasagna A; Bonzano E; Paulli M; Sgarella A; Di Giulio G
Eur Radiol; 2021 Feb; 31(2):920-927. PubMed ID: 32816199
[TBL] [Abstract][Full Text] [Related]
16. Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.
Rakha E; Beca F; D'Andrea M; Abbas A; Petrou-Nunn W; Shaaban AM; Kandiyil A; Smith S; Menon S; Elsheikh S; ElSayed ME; Lee AH; Sharma N
J Clin Pathol; 2019 Dec; 72(12):800-804. PubMed ID: 31350292
[TBL] [Abstract][Full Text] [Related]
17. B3 Breast Lesions: Positive Predictive Value and Follow-Up on a Large Single-Institution Series.
Bernini M; Spolveri F; Tofani L; De Benedetto D; Bicchierai G; Bellini C; Morrone D; Nori Cucchiari J; Bianchi S; Livi L; Orzalesi L; Meattini I
J Surg Res; 2024 Jul; 299():366-373. PubMed ID: 38815523
[TBL] [Abstract][Full Text] [Related]
18. Application of the British National Health Service Breast Cancer Screening Programme classification in 226 breast core needle biopsies: correlation with resected specimens.
Pagni F; Bosisio FM; Salvioni D; Colombo P; Leone BE; Di Bella C
Ann Diagn Pathol; 2012 Apr; 16(2):112-8. PubMed ID: 22056037
[TBL] [Abstract][Full Text] [Related]
19. Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
Hennessy G; Boland MR; Bambrick M; Crone L; Lloyd A; Abdelwahab S; Downey E; Staunton M; Hambly N; Mhuircheartaigh NN; Kerr J; Power C; Duke D; Hill AD
Clin Breast Cancer; 2022 Oct; 22(7):699-704. PubMed ID: 35732544
[TBL] [Abstract][Full Text] [Related]
20. Breast core biopsy reporting categories--An internal validation in a series of 3054 consecutive lesions.
Andreu FJ; Sáez A; Sentís M; Rey M; Fernández S; Dinarès C; Tortajada L; Ganau S; Palomar G
Breast; 2007 Feb; 16(1):94-101. PubMed ID: 16982194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
